Accuray INC's amendment puts TCW's beneficial ownership calculation at 18.7%, using 27,527,916 warrant-issuable common shares alongside 119,439,307 outstanding shares. It also links the Investment to financing changes, governance rights, covenant relief through December 31, 2027, and a possible $15.0 million fee if approval is not obtained.
Key Highlights
- TCW’s Business unit reported an 18.7% beneficial ownership calculation.
- The calculation includes 27,527,916 common shares issuable upon exercise of warrants and July Penny Warrants.
- Accuray and its lenders entered into the Third Amendment on July 29, 2026.
Accuray INC (NASDAQ: ARAY) reported an 18.7% beneficial ownership calculation for TCW’s business unit, based on 27,527,916 common shares issuable upon Warrant exercise. Accuray and its lenders entered into the financing amendment on July 29, 2026.
Approval Terms Carry Financing and Governance Consequences
Following closing, TCW Asset Management Company will have the right to designate Preferred Directors, including Chan W. Galbato and Steven F. Mayer, while Preferred Directors must be included on specified board committees and Series A Preferred Stock holders receive certain class consent rights.
FAQs
Q: What does Accuray’s Schedule 13D/A say about TCW ownership?
A: Accuray’s Schedule 13D/A reports an 18.7% beneficial ownership calculation for TCW’s business unit. The calculation includes 27,527,916 common shares issuable under warrants.
Q: How could the Accuray financing amendment affect shareholders?
A: The amendment provides covenant relief through December 31, 2027 and gives TCW Preferred Director designation rights. Stockholder approval also affects whether a $15.0 million fee becomes payable.
Q: What happens if Accuray stockholders do not approve the issuance?
A: The Cash Investment would become a secured obligation under Accuray’s financing agreement. Accuray would also owe TCW Asset Management Company a fully earned, non-refundable $15.0 million fee.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.